Brown-Driver; Vickie L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Brown-Driver; Vickie L..The latest application filed is for "modulation of transthyretin expression".
- Brown-Driver; Vickie L. - Solana Beach CA
- Brown-Driver; Vickie L. - San Diego CA
| Patent | Date |
|---|---|
| Modulation Of Transthyretin Expression App 20220213474 - Brown-Driver; Vickie L. ; et al. | 2022-07-07 |
| Modulation Of Transthyretin Expression App 20180273949 - Brown-Driver; Vickie L. ; et al. | 2018-09-27 |
| Modulation Of Transthyretin Expression App 20180179532 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179534 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179529 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179528 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179533 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179536 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179537 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179531 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179530 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20180179535 - Brown-Driver; Vickie L. ; et al. | 2018-06-28 |
| Modulation Of Transthyretin Expression App 20160348100 - Brown-Driver; Vickie L. ; et al. | 2016-12-01 |
| Modulation Of Transthyretin Expression App 20150184157 - Brown-Driver; Vickie L. ; et al. | 2015-07-02 |
| Modulation Of Transthyretin Expression App 20120149109 - Brown-Driver; Vickie L. ; et al. | 2012-06-14 |
| Modulation of transthyretin expression Grant 8,101,743 - Brown-Driver , et al. January 24, 2 | 2012-01-24 |
| Antiviral Oligonucleotides Having a Conserved G4 Core Sequence App 20110124715 - Hanecak; Ronnie C. ; et al. | 2011-05-26 |
| Modulation Of Transthyretin Expression App 20090082300 - Brown-Driver; Vickie L. ; et al. | 2009-03-26 |
| Antiviral oligonucleotides having a conserved G4 core sequence App 20070015723 - Hanecak; Ronnie C. ; et al. | 2007-01-18 |
| Modulation of SLC26A2 expression App 20060154885 - Bennett; C. Frank ; et al. | 2006-07-13 |
| Modulation of telomere length by oligonucleotides having a G-core sequence Grant 7,067,497 - Hanecak , et al. June 27, 2 | 2006-06-27 |
| Antisense modulation of interleukin 12 P35 subunit expression App 20050261228 - Bennett, C. Frank ; et al. | 2005-11-24 |
| Modulation of transthyretin expression App 20050244869 - Brown-Driver, Vickie L. ; et al. | 2005-11-03 |
| Antisense modulation of breast cancer-1 expression App 20050026857 - Brown-Driver, Vickie L. ; et al. | 2005-02-03 |
| Antisense modulation of breast cancer-1 expression App 20040014051 - Brown-Driver, Vickie L. ; et al. | 2004-01-22 |
| Modulation of telomere length by oligonucleotides having a G-core sequence App 20030096776 - Hanecak, Ronnie C. ; et al. | 2003-05-22 |
| Antisense inhibition of e2f transcription factor 1 expression Grant 6,187,587 - Popoff , et al. February 13, 2 | 2001-02-13 |
| Oligonucleotides having a conserved G4 core sequence Grant 5,952,490 - Hanecak , et al. September 14, 1 | 1999-09-14 |
| Oligonucleotide therapies for modulating the effects of herpes viruses Grant 5,514,577 - Draper , et al. May 7, 1 | 1996-05-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 